Treatment of atypical central neurocytoma in a child with high dose chemotherapy and autologous stem cell rescue

Journal of Neuro-Oncology

Volumn 97, Issue 3, 2010, Pages 429-437

  Buchbinder, David ^a   Danielpour, Moise ^b   Yong, William H ^c   Salamon, Noriko ^c   Lasky, Joseph ^d  

^a CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

Atypical central neurocytoma; Autologous stem cell rescue; Myeloablative chemotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GLIAL FIBRILLARY ACIDIC PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; IRINOTECAN; ISOTRETINOIN; KI 67 ANTIGEN; MESNA; SYNAPTOPHYSIN; TEMOZOLOMIDE; THIOTEPA; TOPOTECAN; VINCRISTINE;

ABSENCE OF SIDE EFFECTS; ACIDEMIA; AGITATION; AROUSAL; ARTICLE; ATYPICAL CENTRAL NEUROCYTOMA; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BRAIN VENTRICLE PERITONEUM SHUNT; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER RELAPSE; CANCER SURGERY; CASE REPORT; CD34 SELECTION; CEREBROSPINAL FLUID CYTOLOGY; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE INTERVAL; DRUG FEVER; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; FRONTAL LOBE; HISTOPATHOLOGY; HUMAN; HYDROCEPHALUS; HYPOKALEMIA; HYPOMAGNESEMIA; HYPONATREMIA; LATERAL BRAIN VENTRICLE; MENINGEAL METASTASIS; MULTIPLE CYCLE TREATMENT; NEPHROTOXICITY; NEUROEPITHELIOMA; NEUTROPENIA; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRESCHOOL CHILD; SEIZURE; STEM CELL MOBILIZATION;

BRAIN NEOPLASMS; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MENINGEAL NEOPLASMS; NEUROCYTOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77953285480     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-009-0029-8     Document Type: Article

References (30)

1. Schmidt MH, Gottfried ON, von Koch CS, Chang SM, McDermott MW (2004) Central neurocytoma: a review. J Neurooncol 66:377-384
2. Sharma MC, Deb P, Sharma S, Sarkar C (2006) Neurocytoma: a comprehensive review. Neurosurg Rev 29:270-285
3. Rades D, Fehlauer F, Schild SE (2004) Treatment of atypical neurocytomas. Cancer 100:814-817
4. Rades D, Schild SE, Fehlauer F (2004) Defining the best available treatment for neurocytomas in children. Cancer 101:2629-2632
5. Rades D, Schild SE (2006) Treatment Recommendations for the various subgroups of neurocytomas. J Neurooncol 77:305-309
6. Brandes AA, Amistà P, Gardiman M, Volpin L, Danieli D, Guglielmi B, Carollo C, Pinna G, Turazzi S (2000) Monfardini S: Chemotherapy in Patients with Recurrent and Progressive Central Neurocytoma. Cancer 88:169-174
7. Coelho Neto M, Ramina R, deMenesesMS, ArrudaWO,Milano JB (2003) Peritoneal dissemination from central neurocytoma: case report. Arq Neuropsiquiatr 61:1030-1034
8. Dodds D, Nonis J, Mehta M, Rampling R (1997) Central Neurocytoma: a clinical study of response to chemotherapy. J Neurooncol 34:279-283
9. Eng DY, DeMonte F, Ginsberg L, Fuller GN, Jaeckle K (1997) Craniospinal dissemination of central neurocytoma: a report of 2 cases. J Neurosurg 86:547-552
10. Kulkarni V, Rajshekhar V, Haran RP, Chandi SM (2002) Longterm outcome in patients with central neurocytoma following stereotactic biopsy and radiation therapy. Br J Neurosurg 16:126-132
11. Leenstra JL, Rodriguez FJ, Frechette CM, Giannini C, Stafford SL, Pollock BE, Schild SE, Scheithauer BW, Jenkins RB, Buckner JC, Brown PD (2007) Central neurocytoma: management recommendations based on a 35-year experience. Int J Radiat Oncol Biol Phys 67:1145-1154
12. Louis DN, Swearingen B, Linggood RM, Dickersin GR, Kretschmar C, Bhan AK, Hedley-Whyte ET (1990) Central nervous system neurocytoma and neuroblastoma in adults-report of eight cases. J Neurooncol 9:231-238
13. Ogawa Y, Sugawara T, Seki H, Sakuma T (2007) Central neurocytomas with MIB-1 labeling index over 10% showing rapid tumor growth and dissemination. J Neurooncol 79:211-216
14. Sgouros S, Carey M, Aluwihare N, Barber P, Jackowski A (1998) Central neurocytoma: a correlative clinicopathologic and radiologic analysis. Surg Neurol 49:197-204
15. Swinson BM, Friedman WA, Yachnis AT (2006) Pontine atypical neurocytoma: case report. Neurosurgery 58:E990
16. von Koch CS, Schmidt MH, Uyehara-Lock JH, Berger MS, Chang SM (2003) The role of PCV chemotherapy in the treatment of central neurocytoma: illustration of a case and review of the literature. Surg Neurol 60:560-565
17. Amini E, Roffidal T, Lee A, Fuller GN, Mahajan A, Ketonen L, Kobrinsky N, Cairo MS, Wells RJ, Wolff J (2008) Central neurocytoma responsive to Topotecan, Ifosfamide, Carboplatin. Pediatr Blood Cancer 51:137-140
18. Mason WP, Grovas A, Halpern S, Dunkel IJ, Garvin J, Heller G, Rosenblum M, Gardner S, Lyden D, Sands S, Puccetti D, Lindsley K, Merchant TE, O'Malley B, Bayer L, Petriccione MM, Allen J, Finlay JL (1998) Intensive chemotherapy and bone marrow rescue for young children with newly diagnosed malignant brain tumors. J Clin Oncol 16:210-221 (Pubitemid 28041601)
19. Finlay JL, Dhall G, Boyett JM, Dunkel IJ, Gardner SL, Goldman S, Yates AJ, Rosenblum MK, Stanley P, Zimmerman RA, Wallace D, Pollack IF, Packer RJ (2008) Children's Cancer Group. Myeloablative chemotherapy with autologous bone marrow rescue in children and adolescents with recurrent malignant astrocytoma: outcome compared with conventional chemotherapy: a report from the Children's Oncology Group. Pediatr Blood Cancer 51:806-811
20. Broniscer A, Nicolaides TP, Dunkel IJ, Gardner SL, Johnson J, Allen JC, Sposto R, Finlay JL (2004) High-dose chemotherapy with autologous stem-cell rescue in the treatment of patients with recurrent non-cerebellar primitive neuroectodermal tumors. Pediatr Blood Cancer 42:261-267
21. Modak S, Gardner S, Dunkel IJ, Balmaceda C, Rosenblum MK, Miller DC, Halpern S, Finlay JL (2004) Thiotepa-based high dose chemotherapy with autologous stem-cell rescue in patients with recurrent or progressive CNS germ cell tumors. J Clin Oncol 22: 1934-1943
22. Neglia JP, Robison LL, Stovall M, Liu Y, Packer RJ, Hammond S, Yasui Y, Kasper CE, Mertens AC, Donaldson SS, Meadows AT, Inskip PD (2006) New primary neoplasms of the central nervous system in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 98: 1528-1537
23. Gurney JG, Kadan-Lottick NS, Packer RJ, Neglia JP, Sklar CA, Punyko JA, Stovall M, Yasui Y, Nicholson HS, Wolden S, McNeil DE, Mertens AC, Robison LL (2003) Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors: Childhood Cancer Survivor Study. Cancer 97:663-673 (Pubitemid 36125844)
24. Packer RJ,Gurney JG, Punyko JA,Donaldson SS, Inskip PD, Stovall M, Yasui Y, Mertens AC, Sklar CA, Nicholson HS, Zeltzer LK, Neglia JP, Robison LL (2003) Long-term neurologic and neurosensory sequelae in adult survivors of a childhood brain tumor: childhood cancer survivor study. J Clin Oncol 21:3255-3261 (Pubitemid 46606258)
25. Gumireddy K, Sutton LN, Phillips PC, Reddy CD (2003) Alltrans- retinoic acid-induced apoptosis in human medulloblastoma: activation of caspase-3/poly(ADP-ribose) polymerase 1 pathway. Clin Cancer Res 9:4052-4059
26. Damodar Reddy C, Guttapalli A, Adamson PC, Vemuri MC, O'Rourke D, Sutton LN, Phillips PC (2006) Anticancer effects of fenretinide in human medulloblastoma. Cancer Lett 231:262-269
27. Matthay KK, Reynolds CP, Seeger RC, Shimada H, Adkins ES, Haas-Kogan D, Gerbing RB, London WB, Villablanca JG (2009) Long-term results for children with high- risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's oncology group study. J Clin Oncology 27:1007-1013
28. Kieran MW, Turner CD, Rubin JB, Chi SN, Zimmerman MA, Chordas C, Klement G, Laforme A, Gordon A, Thomas A, Neuberg D, Browder T, Folkman J (2005) A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer. J Pediatr Hematol Oncol 27: 573-581
29. Kesari S, Schiff D, Doherty L, Gigas DC, Batchelor TT, Muzikansky A,O'NeillA,Drappatz J, Chen-PlotkinAS, RamakrishnaN, Weiss SE, Levy B, Bradshaw J, Kracher J, Laforme A, Black PM, Folkman J, KieranM,Wen PY (2007) Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults. Neuro Oncol 9:354-363
30. Choi LM, Rood B, Kamani N, Fond DL, Packer RJ, Santi MR, MacDonald TJ (2008) Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors. Pediatr Blood Cancer 50:970-975